Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007

Autores:: Alcedo Ramírez, Alezander D.
Serrano Serrano, Claudia
Rojas, José Luiis
Molina Giraldo, Saulo
Acuña Osorio, Edgar Mariano
Franco, Alejandro
Galvis, Pablo
Arévalo, Ingrid

Tipo de recurso:: Article of journal

Fecha de publicación:: 2009

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_98d49930e04bc6f7accf19ccd8337fa9
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/2432
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007
dc.title.translated.eng.fl_str_mv	Indications of invasive genetic study in a selected population: August 2005 to December 2007
title	Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007
spellingShingle	Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007 translucencia nucal cariotipo síndromes genéticos anomalías estructurales screening prenatal síndrome de Down Nuchal translucency karyotype genetic syndromes structural anomalies prenatal screening Down syndrome
title_short	Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007
title_full	Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007
title_fullStr	Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007
title_full_unstemmed	Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007
title_sort	Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007
dc.creator.fl_str_mv	Alcedo Ramírez, Alezander D. Serrano Serrano, Claudia Rojas, José Luiis Molina Giraldo, Saulo Acuña Osorio, Edgar Mariano Franco, Alejandro Galvis, Pablo Arévalo, Ingrid
dc.contributor.author.spa.fl_str_mv	Alcedo Ramírez, Alezander D. Serrano Serrano, Claudia Rojas, José Luiis Molina Giraldo, Saulo Acuña Osorio, Edgar Mariano Franco, Alejandro Galvis, Pablo Arévalo, Ingrid
dc.subject.spa.fl_str_mv	translucencia nucal cariotipo síndromes genéticos anomalías estructurales screening prenatal síndrome de Down
topic	translucencia nucal cariotipo síndromes genéticos anomalías estructurales screening prenatal síndrome de Down Nuchal translucency karyotype genetic syndromes structural anomalies prenatal screening Down syndrome
dc.subject.eng.fl_str_mv	Nuchal translucency karyotype genetic syndromes structural anomalies prenatal screening Down syndrome
publishDate	2009
dc.date.accessioned.none.fl_str_mv	2009-06-01 00:00:00 2022-02-21T20:37:27Z
dc.date.issued.none.fl_str_mv	2009-06-01
dc.date.available.none.fl_str_mv	2009-06-01 00:00:00 2022-02-21T20:37:27Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.31260/RepertMedCir.v18.n2.2009.538
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/2432
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.31260/RepertMedCir.v18.n2.2009.538
identifier_str_mv	10.31260/RepertMedCir.v18.n2.2009.538 0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/2432 https://doi.org/10.31260/RepertMedCir.v18.n2.2009.538
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2003; (3):CD003252. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88. Invasive Prenatal testing for aneuploidy. Obstet Gynecol. 2007; 110 (6): 1459-67. 3. Cuckle HS, Wald NJ. Principles of screening. In: Wald NJ, editor. Antenatal and neonatal screening. Oxford: Oxford University Press; 2008. p 1–22. Gardner RJ, Sutherland GR. Chromosome abnormalities and genetic counseling. 3rd ed. New York : Oxford University Press; 2004. Milunsky A, Milunsky JM. Genetic counseling: preconception, prenatal, and perinatal. In: Milunsky A, editor. Genetic disorders and the fetus: diagnosis, prevention, and treatment. 5th ed. Baltimore (MD): Johns Hopkins University Press; 2004. p. 1–65. Reddy UM, Wapner RJ. Comparison of first and second trimester aneuploidy risk assessment. Clin Obstet Gynecol. 2007; 50(2): 442-53. Egan JF, Benn PA, Zelop CM, et al. Down syndrome births in the United States from 1989 to 2001. Am J Obstet Gynecol. 2004; 191 (3):1044–48. Nicolaides KH. Screening for chromosomal defects. Ultrasound Obstet Gynecol. 2003; 21 (4): 313-21. Verdin SM, Whitlow BJ, Lazanakis M, Kadir RA, Chatzipapas I, Economides DL. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry. Ultrasound Obstet Gynecol. 2000; 16 (5): 402-6. Shipp TD, Benacerraf BR. Second trimester ultrasound screening for chromosomal abnormalities. Prenat Diagn. 2002; 22 (4): 296–307. Simpson JL. Prenatal cytogenetic screening. Ultrasound Obstet Gynecol. 1995; 5 (1): 3-5 Saller DN, Canick JA. Current methods of prenatal screening for Down syndrome and other fetal abnormalities. Clin Obstet Gynecol. 2008; 51(1): 24-36 Resta RG. Changing demographics of advanced maternal age (AMA) and the impact on the predicted incidence of Down syndrome in the United States: implications for prenatal screening and genetic counseling. Am J Med Genet. 2005; 133A (1):31-6. Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1995; 44 (RR-9):1–12. Seeds W. Diagnostic mid trimester amniocentesis: how safe?. Am J Obstet Gynecol. 2004; 191(2): 607–15. Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol. 2006; 108 (3 pt 1):612–16. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 77. Screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007; 109 (1): 217–28. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated twostage first-trimester screening. Ultrasound Obstet Gynecol. 2005; 25 (3): 221–26. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down’s syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). Health Technol Assess. 2003; 7 (11): 1-77. Borgida AF, Mills AA, Feldman DM, Rodis JF, Egan JF. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol. 2000; 183(4): 937–9. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH. Absence of nasal bone in fetuseswith trisomy 21 at 11–14 weeks of gestation: an observational study. Lancet. 2001; 358 (9294):1665–67. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 11–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol.1998; 12 (6): 380–84. Huggon IC, DeFigueiredo DB, Allan LD. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11–14 weeks of gestation. Heart. 2003; 89 (9): 1071–73. Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 lowrisk women. Lancet. 1986; 1 (8493):1287–93. Ralston SJ, Craigo SD. Ultrasound-guided procedures for prenatal diagnosis and therapy. Obstet Gynecol Clin N Am. 2004; 31 (1) 101–23.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/538/578
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2009 : Abril - Junio
dc.relation.citationendpage.none.fl_str_mv	105
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationstartpage.none.fl_str_mv	97
dc.relation.citationvolume.spa.fl_str_mv	18
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/538
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/501e5eb0-5665-40ac-9ce5-15e73f2f9f80/download
bitstream.checksum.fl_str_mv	42edfa53b2597e3dbdf4d3e84adeb791
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1814355567640051712
spelling	Alcedo Ramírez, Alezander D.53686c571b0aa6b61e7d680897987a85300Serrano Serrano, Claudia0b08ba08c9e10e30a8798590d82f2c3d300Rojas, José Luiis5271cfbff3ae30821b2f67493bc77bb0300Molina Giraldo, Saulo0e00f1a3be12b988817cebfe96830af5500Acuña Osorio, Edgar Mariano4bfeb967187d5fab16f082c27511c94b500Franco, Alejandro48b5faa806053cd18a5d12bbf9d27e43500Galvis, Pablofda819ca2da347c0d34eac4683b1733fArévalo, Ingridafa925f53f4283d9e18b1d1c012a5e8b5002009-06-01 00:00:002022-02-21T20:37:27Z2009-06-012009-06-01 00:00:002022-02-21T20:37:27ZFundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/538translucencia nucalcariotiposíndromes genéticosanomalías estructuralesscreening prenatalsíndrome de DownNuchal translucencykaryotypegenetic syndromesstructural anomaliesprenatal screeningDown syndromeIndicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007Indications of invasive genetic study in a selected population: August 2005 to December 2007application/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v18.n2.2009.5380121-7372https://repositorio.fucsalud.edu.co/handle/001/24322462-991Xhttps://doi.org/10.31260/RepertMedCir.v18.n2.2009.538spaAlfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2003; (3):CD003252.American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88. Invasive Prenatal testing for aneuploidy. Obstet Gynecol. 2007; 110 (6): 1459-67. 3. Cuckle HS, Wald NJ. Principles of screening. In: Wald NJ, editor. Antenatal and neonatal screening. Oxford: Oxford University Press; 2008. p 1–22.Gardner RJ, Sutherland GR. Chromosome abnormalities and genetic counseling. 3rd ed. New York : Oxford University Press; 2004.Milunsky A, Milunsky JM. Genetic counseling: preconception, prenatal, and perinatal. In: Milunsky A, editor. Genetic disorders and the fetus: diagnosis, prevention, and treatment. 5th ed. Baltimore (MD): Johns Hopkins University Press; 2004. p. 1–65.Reddy UM, Wapner RJ. Comparison of first and second trimester aneuploidy risk assessment. Clin Obstet Gynecol. 2007; 50(2): 442-53.Egan JF, Benn PA, Zelop CM, et al. Down syndrome births in the United States from 1989 to 2001. Am J Obstet Gynecol. 2004; 191 (3):1044–48.Nicolaides KH. Screening for chromosomal defects. Ultrasound Obstet Gynecol. 2003; 21 (4): 313-21.Verdin SM, Whitlow BJ, Lazanakis M, Kadir RA, Chatzipapas I, Economides DL. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry. Ultrasound Obstet Gynecol. 2000; 16 (5): 402-6.Shipp TD, Benacerraf BR. Second trimester ultrasound screening for chromosomal abnormalities. Prenat Diagn. 2002; 22 (4): 296–307.Simpson JL. Prenatal cytogenetic screening. Ultrasound Obstet Gynecol. 1995; 5 (1): 3-5Saller DN, Canick JA. Current methods of prenatal screening for Down syndrome and other fetal abnormalities. Clin Obstet Gynecol. 2008; 51(1): 24-36Resta RG. Changing demographics of advanced maternal age (AMA) and the impact on the predicted incidence of Down syndrome in the United States: implications for prenatal screening and genetic counseling. Am J Med Genet. 2005; 133A (1):31-6.Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1995; 44 (RR-9):1–12.Seeds W. Diagnostic mid trimester amniocentesis: how safe?. Am J Obstet Gynecol. 2004; 191(2): 607–15.Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol. 2006; 108 (3 pt 1):612–16.American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 77. Screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007; 109 (1): 217–28.Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated twostage first-trimester screening. Ultrasound Obstet Gynecol. 2005; 25 (3): 221–26.Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down’s syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). Health Technol Assess. 2003; 7 (11): 1-77.Borgida AF, Mills AA, Feldman DM, Rodis JF, Egan JF. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol. 2000; 183(4): 937–9.Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH. Absence of nasal bone in fetuseswith trisomy 21 at 11–14 weeks of gestation: an observational study. Lancet. 2001; 358 (9294):1665–67.Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 11–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol.1998; 12 (6): 380–84.Huggon IC, DeFigueiredo DB, Allan LD. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11–14 weeks of gestation. Heart. 2003; 89 (9): 1071–73.Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 lowrisk women. Lancet. 1986; 1 (8493):1287–93.Ralston SJ, Craigo SD. Ultrasound-guided procedures for prenatal diagnosis and therapy. Obstet Gynecol Clin N Am. 2004; 31 (1) 101–23.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/538/578Núm. 2 , Año 2009 : Abril - Junio10529718Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2594https://repositorio.fucsalud.edu.co/bitstreams/501e5eb0-5665-40ac-9ce5-15e73f2f9f80/download42edfa53b2597e3dbdf4d3e84adeb791MD51001/2432oai:repositorio.fucsalud.edu.co:001/24322024-02-02 13:11:29.911https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Indicaciones de estudio genético invasivo en una población seleccionada: Agosto de 2005 a diciembre de 2007

Publicaciones similares